<DOC>
	<DOC>NCT01342055</DOC>
	<brief_summary>A Randomized, Open Label, Single dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and MegaceÂ® under Fed Conditions in Healthy Male Volunteers.</brief_summary>
	<brief_title>Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Is a healty male between 20 and 55 years old Has BMI result between 19 and 26 kg/m2 at screening Is willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures Agrees to use an adequate means of contraception during clinical trials Has had a serious illness or medical condition(s) regarding liver, kidney, gastrointestines, pulmonary systems, etc. Has had a medical history of gastrointestinal diseases which might affect drug absorption (i.e. Crohn's disease, ulcer) or surgical history. Is allergic against Megestrol acetate or other drugs (Aspirin, NSAIDs, Antibiotics, etc.) or against foods, or has an clinically serious allergic history</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>